CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Onyx Therapeutics, Inc. v. Dr. Reddy's Laboratories, Inc.

1:16-cv-01011

Overview

Case Number 1:16-cv-01011
Filing Date 2016-11-01
Status Terminated
Termination Date 2019-05-16
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Dr. Reddy's Laboratories, Ltd. Operating Company

Represented By

2 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Dr. Reddy's Laboratories, Inc. Operating Company

Represented By

4 Attorneys Listed

David Ellis Moore

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Constance S. Huttner

Email: chuttner@windelsmarx.com

Bindu Ann George Palapura

Potter Anderson & Corroon, LLP

Tel: +1 (302) 984-6000
Fax: +1 (302) 778-6000

1313 N. Market St., Hercules Plaza, 6th Flr., P.O. Box 951

Anandita Vyakarnam

Email: avyakarnam@windelsmarx.com

Plaintiff

Onyx Therapeutics, Inc. Operating Company

Represented By

6 Attorneys Listed

Wendy A. Whiteford

Email: wendy@amgen.com

Margaret A. O'Boyle

Email: moboyle@omm.com

Lisa Barons Pensabene

O'Melveny & Myers LLP

Tel: +1 (212) 326-2077
Fax: +1 (212) 326-2061

7 Times Square, Times Square Tower, New York, NY 10036

Brian Kao

UNDELIVERABLE 6/11/2020

UNDELIVERABLE 6/11/2020

Maryellen Noreika

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Jack B. Blumenfeld

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 3 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 4 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (3): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (4 found):
U.S. Courts: 4
U.S. District Court 2016-11-08
1:16-cv-01039

Onyx Therapeutics, Inc. v. Apotex Inc.

Asserted Patent
Status: DED
U.S. District Court 2016-11-08
1:16-cv-01036

Onyx Therapeutics, Inc. v. InnoPharma Inc.

Asserted Patent
Status: DED
U.S. District Court 2016-10-26
1:16-cv-00999

Onyx Therapeutics, Inc. v. MSN Pharmaceuticals, Inc.

Asserted Patent
Status: DED
U.S. District Court 2016-10-26
1:16-cv-01000

Onyx Therapeutics, Inc. v. Sagent Pharmaceuticals, Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US7737112
Composition for enzyme inhibition
Filed: 2005-12-07
Issued: 2010-06-15
Active (1.1 yrs remaining) +742d PTA
Expires: 2027-12-19

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+742 days) / Cellect Scrutiny β€” Over 742 days of PTA awarded. Susceptible to In re Cellect double patenting invalidation if continuation patents in the same family expire earlier.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

3

Dispositive

0

Granted

0

Denied

0

Pending / Review

3

Motions by Category

Procedural / Extension Motion 2 Claim Construction / Markman Filing 1

Key Dispositive Motions & Rulings

Claim Construction / Markman Filing Pending / Under Review
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. These actions are consolidated for purposes of discovery and all paper...
Entry #20 • 2017-04-18 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for the parties to submit a proposed Scheduling Order to March 29, 2017 - filed by Onyx Therapeutics, Inc.. (Noreika, Maryellen) (Ent...
Entry #18 • 2017-03-22 Document →
Procedural / Extension Motion Pending / Under Review
STIPULATION TO EXTEND TIME for plaintiff to answer, move, or otherwise respond to Defendants' counterclaim to January 31, 2017 - filed by Onyx Therapeutics, Inc...
Entry #14 • 2017-01-11 Document →

Docket Entries

(22 total)
Pleading / Complaint

COMPLAINT for Patent Infringemnet filed against Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2023063.) - filed by Onyx Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(klc) (Entered: 11/01/2016)

Entry #1 • 2016-11-01
1
Pleading / Complaint

COMPLAINT for Patent Infringemnet filed against Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2023063.) - filed by Onyx Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(klc) (Entered: 11/01/2016)

Entry #1 • 2016-11-01
2
Pleading / Complaint

COMPLAINT for Patent Infringemnet filed against Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2023063.) - filed by Onyx Therapeutics, Inc. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(klc) (Entered: 11/01/2016)

Entry #1 • 2016-11-01
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (klc) (Entered: 11/01/2016)

Entry #2 • 2016-11-01
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 20, 2016. Date of Expiration of Patent: December 7, 2027.Thirty Month Stay Deadline: 1/20/2020 +. (klc) (Entered: 11/01/2016)

Entry #3 • 2016-11-01
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc